3Jaffa A, Yaron Y, Har Joov J, Amester R, Legum C, Lessing JB. Doppler velocimetry of the umbilical artery as a predictor so outcome in pregnancies characterized by elevated maternal serum and normal amniotic fluid alpha-fetoprotein. Fetal Dissgn Ther,1997, 12: 85-88.
4Brazerol WF, Grover S, Donnenfeld AE. Unexplained elevated maternal serum α-fetoprotein levels and perinatal outcome in an urban clinic population. Am J Obstet Gynecol, 1994, 171: 1030.
5Triple marker screening for trisomy 21, trisomy 18 and open neural tube defects in singleton pregnancies of native Japanese pregnant women. J Obstet Gynaecol Res, 2000, 12 (1): 26.
6Assay precision of serum alpha fetoprotein in antenatal screening for neural tube defects and Down's syndrome. Wald N J, Hackshaw AK, George LM. J Med Screen, 2000, 7 (3): 168.
7Milunsky A, Alpert E, Neff R, Frigoletto F. Prenatal diagnosis of neural tube defect: maternal serum alpha-fetopriteinscreening. Obstst Gynecol, 1980, 55 (1): 60-66.
8Wald N J, Densem JW, Smith D et al. Four marker serum screening for Down' s syndrome. Prenat Diagn, 1994, 14:707.
9Brock D J, Barron L, Jelen Pwatt M, Scrimgeour JB. Maternal serumalpha-fetoprotein measurements as an early indicator of low birthweight. Lancet, 1977, 2:267-268.
